Страна: Австралія
мова: англійська
Джерело: Department of Health (Therapeutic Goods Administration)
fludarabine phosphate, Quantity: 50 mg
Hospira Australia Pty Ltd
Fludarabine phosphate
Injection, intravenous infusion
Excipient Ingredients: sodium hydroxide; mannitol
Intravenous
1 X 3 mL
Medicine Listed (Export Only)
Not scheduled. Not considered by committee
Fludarabine Phosphate for Injection USP is indicated for second line therapy in patients with chronic lymphocytic leukemia (CLL) and low-grade non-Hodgkin's lymphoma (Lg-NHL) who have failed other conventional therapies.
Visual Identification: A white intact plug; Container Type: Vial; Container Life Time: 2 Years
Listed (Export Only)
2008-07-23